Golidocitinib and Chidamide for Cutaneous T-Cell Lymphoma

Clinical trial NCT07754890 · RECRUITING

Trial details

NCT number: NCT07754890
Sponsor: Peking Union Medical College Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cutaneous T-cell Lymphoma (CTCL)

Start date: 2025-08-26
Primary completion: 2028-12-31
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.